Clinical Trial Update: A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma [Phase 4]

View source ↗

Summary

Phase 4 multicenter trial investigating ixazomib with pomalidomide or with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Pomalidomide (Pomalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma | Phase 4 | Status: WITHDRAWN